Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Melanoma/Skin Cancer
  •  Gynecological Cancers
  •  Ovarian Cancer
  •  Colorectal Cancer
  •  Cervical Cancer
  •  Breast Cancer
  •  Radiation Therapy
  •  Leukemia

Abstract

Citation: Clin Oncol. 2016;1(1):1085.DOI: 10.25107/2474-1663.1085

Pancreatic Alteration Induced by Incretins is Consistent with the Changes at the Early Stages of Pancreatic Carcinogenesis in the Hamster Model

Pour PM and Talmon G

Department of Pathology, UNMC Eppley Cancer Center, USA
Department of Pathology and Microbiology, University of Nebraska, Medical Center, USA

*Correspondance to: Parviz M Pour 

 PDF  Full Text Research Article | Open Access

Abstract:

Background: GLP-1 analogs and DDP4 inhibitors, known as incretins, are used for the treatment of type 2 diabetes. Although several published clinical and experimental studies point to the beneficial effects of these drugs with negligible mild side effects, except for acute pancreatitis, the detailed long-term effects of these drugs on the pancreas was missing. A recent report by the investigators at UCLA showing a profound expansion of pancreatic endocrine cells, hyperplasia of ductal epithelium and induction of endocrine lesions initiated serious concern about the safety of these drugs.
Methods: These alterations were almost identical to those found at the early stages of pancreatic carcinogenesis in the hamster model. Therefore, in the present study, we compared the alterations published by the UCLA investigators with the alterations of the pancreas occurring during pancreatic carcinogenesis in the hamster model. Results and
Discussion: The results heighten the safety concern of these drugs and suggest that in cretins should be considered promoters of silent malignant pancreatic lesions. The use of these drugs should be restricted to genuine long-standing diabetics and be withheld from individuals with new-onset diabetes (Type 3 diabetes) who exhibit asymptomatic pancreatic cancer.

Keywords:

Glp-1; Pancreatic cancer; Islet

Cite the Article:

Pour PM, Talmon G. Pancreatic Alteration Induced by Incretins is Consistent with the Changes at the Early Stages of Pancreatic Carcinogenesis in the Hamster Model. Clin Oncol. 2016; 1: 1085.

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Detection of Tumor-Related Biomarkers in Hepatocellular Carcinoma Patients by Sequencing Circulating Cell-Free DNA
 Abstract  PDF  Full Text
An Unusual Case of Papillary Thyroid Carcinoma with Solitary Cerebral Metastases Mimicking Cavernous Hemangioma
 Abstract  PDF  Full Text
View More...